The reduction in ADS count and aggregate offering size signals weaker demand or pricing recalibration. Watch for the final IPO price relative to the Singapore-listed ordinary share (9MT, last S$0.76 on June 9, 2026, ~US$5.47/ADS equivalent) — if priced at a discount, it reflects institutional caution. Monitor the effectiveness date and whether Nasdaq listing approval is received. Post-IPO, key catalysts are customer qualification cycles and mass production orders, which the company has not yet secured.
Executive Summary
MetaOptics Ltd, a Cayman Islands holding company with operations in Singapore and the US, files Amendment No. 2 to its F-1 registration statement for a US IPO of 3,000,000 ADSs (each representing 12 ordinary shares) on the Nasdaq Capital Market under ticker 'MOT'. The company is a vertically integrated metalens technology firm that has generated limited revenue (S$787k in FY2025) and remains loss-making (S$5.4m net loss in FY2025). The offering size has been reduced from 4M ADSs (at $5-$7/ADS) in the prior May 18 amendment to 3M ADSs at $5-$7/ADS, and the maximum aggregate offering size was decreased from ~$38.8M to ~$25.0M.
Key Financial Metrics
Key Facts
- IPO offering cut from 4,000,000 ADSs (May 18 amendment) to 3,000,000 ADSs in this amendment
- Expected IPO price range remains $5.00-$7.00 per ADS
- Maximum aggregate offering size reduced to ~$25.0M from ~$38.8M (reduction of ~$13.4M)
- FY2025 revenue of S$787,388 (up 891% YoY from S$79,440), but net loss widened to S$5,445,573 (from S$1,950,882)
- Single customer (Haur-Jye Technology) accounted for 74.6% of FY2025 revenue; single supplier (MMI Systems) for 81% of purchases
- Company has not commenced mass production of metalenses (defines mass production as 1M units/year) and lacks critical mass of orders
- Material weaknesses in ICFR identified, including restatements of previously issued financial statements
- KY-based holding company; operations via Singapore and US subsidiaries; no VIE structure
- Net proceeds estimated at ~US$14.3M (mid-point), primarily for US expansion
- 180-day lock-up on >50% of shares; underwriters: Roth Capital, Benchmark
Financial Impact
Offering size reduced by ~25% from 4M to 3M ADSs; max aggregate offering lowered from ~$38.8M to ~$25.0M. Net proceeds estimated at ~$14.3M at mid-point. FY2025 revenue S$787K; net loss S$5.4M; accumulated losses S$11.0M.
Risk Factors
- Offering downsize may indicate tepid institutional demand
- Pre-revenue / sub-$1M revenue base with widening losses
- Single-customer concentration (74.6%) and single-supplier reliance (81%)
- Mass production has not commenced; no critical mass of purchase orders
- Material weaknesses in ICFR with restated financials
- Early-stage technology with long (≥12-month) customer qualification cycles and unproven commercial scalability
- Dual listing on SGX Catalist and Nasdaq may fragment liquidity
- License-dependent IP with commercialization milestones that have already required waivers
- Tiny employee base (7 total) with lean management
- U.S. tariff exposure and FX risk (SGD reporting, revenues in USD/SGD)
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| F-1/A Filing (Primary) | 0001213900-26-067164 |
| Document: ea027035412ex-fee.htm | 0001213900-26-067164 |
| Document: ea027035412ex23-1.htm | 0001213900-26-067164 |
| Document: 0001213900-26-067164-index-headers.html | 0001213900-26-067164 |
| Document: 0001213900-26-067164-index.html | 0001213900-26-067164 |
| Document: 0001213900-26-067164.txt | 0001213900-26-067164 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers